- 英文名称
- Liranaftate
- 分子式
- C18H20N2O2S
- 分子量
- 328.43
- 中文别名
- O-(5,6,7,8-四氢萘-2-基)(6-甲氧基吡啶-2-基)(甲基)氨基硫代甲酸酯; N-(6-甲氧基-2-吡啶基)-N-甲基氨基硫代甲酸(5,6,7,8-四氢)-2-萘酯; 利拉柰酯; 利拉萘脂; O-(5,6,7,8-Tetrahydronaphthalen-2-yl) (6-methoxypyridin-2-yl)(methyl)carbamothioate; O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxypyridin-2-yl)-N-methylcarbamothioate; Liranaftatum; O-(5,6,7,8-Tetrahydro-2-naphthalenyl) (6-methoxy-2-pyridinyl)methylcarbamothioate; M-732; piritetrate; O-(5,6,7,8-Tetrahydronaphthalen-2-yl)-(6-methoxypyridin-2-yl)methylthiocarbamat; Liranaftato; Zefnart; (6-Methoxy-2-pyridinyl)methylcarbamothioic Acid O-(5,6,7,8-Tetrahydro-2-naphthalenyl) Ester; Carbamothioic acid, N-(6-methoxy-2-pyridinyl)-N-methyl-, O-(5,6,7,8-tetrahydro-2-naphthalenyl) ester; Liranaftate (JAN); LNF; LIRANAFATE
- 用途
- 利拉萘酯是第三代硫代氨基甲酸类抗真菌药,属角鲨烯环氧化酶抑制剂,通过抑制真菌细胞膜角鲨烯环氧化反应阻碍麦角甾醇合成发挥抗真菌作用;抗真菌活性为托萘酯的8倍,抗皮肤癣菌效果优于克霉唑;对皮肤丝状真菌(发癣菌属、小孢子菌属、表皮癣菌属)有强抗真菌作用,对其他丝状真菌、暗色真菌、双态性真菌也显示抗真菌作用;适用于治疗头癣、手癣、脚癣、足癣、甲癣、体癣、股癣、花斑癣及念珠菌性外阴阴道炎